23 results
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Medicine type
Orphan medicine Remove Orphan medicine filter
Accelerated assessment Remove Accelerated assessment filter
Conditional approval Remove Conditional approval filter
Biosimilar Remove Biosimilar filter
Additional monitoring Remove Additional monitoring filter
Opinion status
Positive Remove Positive filter
-
List item
Summary of opinion: Livogiva
teriparatide, opinion date: 25/06/2020, Positive, Last updated: 26/06/2020 -
List item
Summary of opinion: Epclusa
sofosbuvir / velpatasvir, opinion date: 25/06/2020, Positive, Last updated: 26/06/2020 -
List item
Summary of opinion: Qutavina
teriparatide, opinion date: 25/06/2020, Positive, Last updated: 26/06/2020 -
List item
Summary of opinion: Zavicefta
ceftazidime / avibactam, opinion date: 25/06/2020, Positive, Last updated: 26/06/2020 -
List item
Summary of opinion: Crysvita
burosumab, opinion date: 23/07/2020, Positive, Last updated: 24/07/2020 -
List item
Summary of opinion: Calquence
acalabrutinib, opinion date: 23/07/2020, Positive, Last updated: 24/07/2020 -
List item
Summary of opinion: Ayvakyt
avapritinib, opinion date: 23/07/2020, Positive, Last updated: 24/07/2020 -
List item
Summary of opinion: HyQvia
human normal immunoglobulin, opinion date: 23/07/2020, Positive, Last updated: 24/07/2020 -
List item
Summary of opinion: Shingrix
herpes zoster vaccine (recombinant, adjuvanted), opinion date: 23/07/2020, Positive, Last updated: 24/07/2020 -
List item
Summary of opinion: Imfinzi
durvalumab, opinion date: 23/07/2020, Positive, Last updated: 24/07/2020 -
List item
Summary of opinion: Rozlytrek
entrectinib, opinion date: 28/05/2020, Positive, Last updated: 29/05/2020 -
List item
Summary of opinion: Kalydeco
ivacaftor, opinion date: 23/07/2020, Positive, Last updated: 24/07/2020 -
List item
Summary of opinion: Olumiant
baricitinib, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Zavicefta
ceftazidime / avibactam, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Flucelvax Tetra
influenza vaccine surface antigen inactivated prepared in cell cultures, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Zejula
niraparib, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Kalydeco
ivacaftor, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Kalydeco
ivacaftor, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Symkevi
tezacaftor / ivacaftor, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Deltyba
delamanid, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Tecentriq
atezolizumab, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Nyvepria
pegfilgrastim, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020 -
List item
Summary of opinion: Obiltoxaximab SFL
obiltoxaximab, opinion date: 17/09/2020, Positive, Last updated: 18/09/2020